3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
31
Recurrence
4
Neoplasms, Plasma Cell
3
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin Light-chain Amyloidosis
1
HIV Infections
1
Carcinoma, Non-Small-Cell Lung
1
Anemia, Sickle Cell
1
Interventions
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
5
Whole-Body Irradiation
4
Busulfan
4
Biopsy
4
Specimen Handling
3
Injections
3
Cytarabine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporine
2
CPX-351
2
Azacitidine
2
treosulfan
1
peginterferon alfa-2b
1
olutasidenib
1
itacitinib
1
canakinumab
1
aldesleukin
1
X-Rays
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Bortezomib
×
30 days
×
Clear all
No trials found.